As the aberrant splice variant expression of the EAAT2 glutamate transporter is used to suppress the normal variant expression in glioma cells [33, 38], the aberrant splice variant expression of hCNT1-IR may also be used to downregulate the expression on the normal hCNT1 variant in cancer. This evidence concerns the gene INSR and cancer.